Abstract:BackgroundEndoplasmic reticulum (ER) stress had a crucial impact on cell survival, proliferation, and metastasis in various cancers. However, the role of ER stress in lung adenocarcinoma remains unclear. MethodGene expression and clinical data of lung adenocarcinoma (LUAD) samples were extracted from The Cancer Genome Atlas (TCGA) and three Gene Expression Omnibus (GEO) datasets. ER stress score (ERSS) was constructed based on hub genes selected from 799 ER stress-related genes by least absolute shrinkage and selection operator (LASSO) regression. A Cox regression model, integrating ERSS and the TNM stage, was developed to predict overall survival (OS) in TCGA cohort and was validated in GEO cohorts. Gene set enrichment analysis (GSEA), single-sample GSEA (ssGSEA), and gene mutation analyses were performed to further understand the molecular features of ERSS. The tumor immune infiltration was evaluated by ESTIMATE, CIBERSORT, and xCell algorithms. The receiver operating characteristic (ROC) curves were used to evaluate the predictive value of the risk model. p< 0.05 was considered statistically significant. ResultsOne hundred fifty-seven differentially expressed genes (DEGs) were identified between tumor and para-carcinoma tissues, and 45 of them significantly correlated with OS. Next, we identified 18 hub genes and constructed ERSS by LASSO regression. Multivariate analysis demonstrated that higher ERSS (p< 0.0001, hazard ratio (HR) = 3.8, 95%CI: 2.8-5.2) and TNM stage (p< 0.0001, HR = 1.55, 95%CI: 1.34-1.8) were independent predictors for worse OS. The prediction model integrating ERSS and TNM stage performed well in TCGA cohort (area under the curve (AUC) at five years = 0.748) and three GEO cohorts (AUC at 5 years = 0.658, 0.717, and 0.739). Pathway enrichment analysis showed that ERSS significantly correlated with unfolded protein response. Meanwhile, pathways associated with the cell cycle, growth, and metabolism were significantly enriched in the high ERSS group. Patients with SMARCA4, TP53, and EGFR mutations showed significantly higher ERSS (p = 4e-04, 0.0027, and 0.035, respectively). Tissues with high ERSS exhibited significantly higher infiltration of M1 macrophages, activated dendritic cells, and lower infiltration of CD8+ T cells and B cells, which indicate an activated tumor antigen-presenting but suppressive immune response status. ConclusionWe developed and validated an ER stress-related risk model that exhibited great predictive value for OS in patients with LUAD. Our work also expanded the understanding of the role of ER stress in LUAD.

Genomic and clinical features of endoplasmic reticulum stress factor in digestive system pan-cancer studies

A risk signature based on endoplasmic reticulum stress-associated genes predicts prognosis and immunity in pancreatic cancer

Identification of Endoplasmic Reticulum Stress-Related Subtypes, Infiltration Analysis of Tumor Microenvironment, and Construction of a Prognostic Model in Colorectal Cancer.

Comprehensive analysis of bulk and single-cell transcriptomic data reveals a novel signature associated with endoplasmic reticulum stress, lipid metabolism, and liver metastasis in pancreatic cancer

Pan-Cancer Analysis of Endoplasmic Reticulum Stress-Related Molecular Features and Drug Resistance

Characteristics of endoplasmic reticulum stress in colorectal cancer for predicting prognosis and developing treatment options

A novel defined risk signature of endoplasmic reticulum stress-related genes for predicting the prognosis and immune infiltration status of ovarian cancer

Identification and validation of endoplasmic reticulum stress-related genes that enhance immunotherapy in colon cancer

Endoplasmic Reticulum Stress-Related Signature Predicts Prognosis and Drug Response in Clear Cell Renal Cell Carcinoma

Bioinformatics-Based Identification of Tumor Microenvironment-Related Prognostic Genes in Pancreatic Cancer

Endoplasmic reticulum stress-a key guardian in cancer

Development and Validation of a Prognosis Prediction Model Based on 18 Endoplasmic Reticulum Stress-Related Genes for Patients with Lung Adenocarcinoma.

Endoplasmic reticulum stress-related genes as prognostic and immunogenic biomarkers in prostate cancer

Modulating Endoplasmic Reticulum Stress in Gastrointestinal Cancers: Insights from Traditional Chinese Medicine

Endoplasmic Reticulum Stress and Tumor Microenvironment in Bladder Cancer: The Missing Link

An Integrated Machine Learning Framework for Developing and Validating a Prognostic Risk Model of Gastric Cancer Based on Endoplasmic Reticulum Stress-Associated Genes

An endoplasmic reticulum stress related signature for clinically predicting prognosis of breast cancer patients

Validation of endoplasmic reticulum stress-related gene signature to predict prognosis and immune landscape of patients with non-small cell lung cancer

Comprehensive analysis of the biological functions of endoplasmic reticulum stress in prostate cancer

Construction of a Prognostic Model for Colon Cancer by Combining Endoplasmic Reticulum Stress Responsive Genes

Unfolded protein response activated by endoplasmic reticulum stress in pancreatic cancer: potential therapeutical target